EX-10.1 2 ex10-1.htm DISTRIBUTION AND COMMERCIALIZATION AGREEMENT Adamis Pharmaceuticals, Corporation 10-Q Exhibit [10.1] Execution Version [*] Designates Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential...Distribution and Commercialization Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionThis Distribution and Commercialization Agreement (the “Agreement”) is made effective as of the Effective Date by and between Adamis Pharmaceuticals Corporation, a corporation organized under the laws of Delaware (the “Company”), with an office located at 11682 El Camino Real, Suite #300, San Diego, CA 92130 and Sandoz Inc., a corporation organized under the laws of Colorado, with an office at 100 College Road West, Princeton, New Jersey 08540 (“Sandoz”). Sandoz and the Company may hereafter be referred to collectively as the “Parties” and individually as a “Party”.
DISTRIBUTION AND COMMERCIALIZATION AGREEMENTDistribution and Commercialization Agreement • November 9th, 2018 • Adamis Pharmaceuticals Corp • Pharmaceutical preparations • New York
Contract Type FiledNovember 9th, 2018 Company Industry JurisdictionThis Distribution and Commercialization Agreement (the “Agreement”) is made effective as of the Effective Date by and between Adamis Pharmaceuticals Corporation, a corporation organized under the laws of Delaware (the “Company”), with an office located at 11682 El Camino Real, Suite #300, San Diego, CA 92130 and Sandoz Inc., a corporation organized under the laws of Colorado, with an office at 100 College Road West, Princeton, New Jersey 08540 (“Sandoz”). Sandoz and the Company may hereafter be referred to collectively as the “Parties” and individually as a “Party”.